Join today and have your say! It’s FREE!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}

Join today with :


By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Sign in with existing account
Please Try Again
{{ error }}

Sign In With :


Password Hint : {{passwordHint}}
Forgot Password?
Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Opko Health Inc. OPK

"Opko Health is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a global supply-chain operation and holding company in Ireland. Opko also owns a specialty active pharmaceutical ingredients manufacturer in Israel. The company's bio-reference testing business consists of routine testing and esoteri

View modes: 

still holding this stock

and it is a longer term hold,that's the problem with biotechs,so glta.  rate and reply

Theralase up 15 percent today

This stock could make a lot of investors multimillionaires   rate and reply

C.BOSS Appoints Head of Sales w/ Expertise in Edible Mushroom Wellness Products

The global edible mushrooms market is expected to grow at a CAGR of 7.95% to grow to US$62 billion by 2023, increasing from US$42 billion in 2018, according to a report by Research and Markets. Grand View Research reports that the global healthy snacks market size is expected to reach US$32 billion by 2025. more

Seeking another celgene

a penny stock that could skyrocket into a several hundred dollar stock  Could theralase  v.tlt  be that stock.theralase undiscovered small Canadian stock That May hold the keys for more

flat lining right now

but it will breakout to the upside with an announcement soon,so glta.  rate and reply

solid play for the health care sector

there are lots of insiders in this one with their own money put into it,so glta.  rate and reply

steady climb up from

the lows,it looks like a $5 plus change coming up this year,so glta shareholders.  rate and reply

big buying by insiders

for this stock is encouraging for shareholders,so glta.  rate and reply

added more of this one

big bargain stock at these prices,so glta, at $2.87 per share as the year end rally gets going.  rate and reply

waiting for this hold

it is a wild ride for me,but I am willing to keep it for a while more,so glta.  rate and reply

still holding this one

there was insider buying last while,so something's coming soon,glta.  rate and reply

bought this for

diversification,but I don't know anything about this one other than the insiders loaded up big time a while ago,seriously wonder what this stock is about as it is a health stock,but it would more

chart is saying that

we are going up,up,up from this point forward,so glta.  rate and reply

still holding this one

big breakout here,so I am expecting big returns here,glta.  rate and reply

going up at a steady rate

in a down market,so this is really good for us shareholders,will go past $5 per share soon,there are absolutely no worries for this one right now,glta.  rate and reply

levelling off nicely

lot of insider buying all of this month,so glta.  rate and reply

resuming its climb

up,great time to be in healthcare,so glta.  rate and reply

still holding this one

good for diversification away from oil stocks,since things are somewhat so problematic at this time with the wingnuts in the whitehouse,so glta.  rate and reply

big upswing today

hope it is the start of a big climb,lots of insider buying over the past few weeks,soglta.  rate and reply

bought this one today

for $4.23 per share,good healthcare play,big insider buying last week,so glta.  rate and reply


Get our FREE StockTalk Investor Guides by sector as they are released!

Stay on top of sector specific news, get industry leaders insights and our best content, delivered to your email.

You are already a member! Please enter your password to sign in.